When the tumor was allowed to grow until day 42, anti-IFNAR1 antibody treatment significantly abrogated the tumor growth control effect observed with the unmodified OVA-LNP in the isotype control group (Figure 6B). Here, IFNAR1 is linked to neoplasm.